<DOC>
	<DOCNO>NCT01788943</DOCNO>
	<brief_summary>The investigator propose use positron emission tomography ( PET ) image determine whether nicotinic receptor availability pretreatment predict smoke cessation success . The investigator recruit 30 smoker enrol Pharmacogenetics Nicotine Addiction Treatment clinical trial . The investigator measure nicotinic receptor availability use PET radioligand 2- [ 18F ] FA , overnight abstinence prior initiation treatment .</brief_summary>
	<brief_title>Nicotine Receptor Levels Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Participants male female smoker age 18 65 must enrol ( consented meet eligibility requirement ) ongoing PNAT trial [ NCT01314001 ] order participate substudy . They must able provide inform consent weigh less 300 lb ( due limitation PET MRI scanner ) . In addition exclusion criterion use PNAT trial [ NCT01314001 ] , participants trial exclude meet follow criterion : ImagingRelated 1 . Weigh 299 lb . 2 . Selfreported history head trauma brain ( CNS ) tumor . 3 . Selfreported history claustrophobia ( contraindicate PET MRI ) . 4 . Cochlear implant bilateral hearing aid . 5 . Pacemakers , certain metallic implant , presence metal eye contraindicate MRI . 6 . History gunshot wound ( include BB gun ) . 7 . Circumstances condition may interfere magnetic resonance imaging ( MRI ) . 8 . CO read great 15ppm PET Scan Session ( least 50 % reduction PNAT Intake Session ) . 9 . BrAC read great equal 0.01 PET Scan Session . 10 . Positive urine drug screen cocaine , phencyclidine , amphetamine , methamphetamine , tricyclic antidepressant , opiate , methadone , benzodiazepine , barbiturate PNAT Intake Session PET Scan Session . 11 . Positive urine pregnancy ( female ) screen PET Scan Session and/or MRI Scan Session . 12 . Inability give blood PET Scan Session ( blood sample require analyze PET data ) . 13 . Prior exposure radioactive tracer image study medical reason may exclusionary . General 1 . Any medical condition , illness , disorder concomitant medication could compromise participant safety treatment , determine Principal Investigator Coinvestigators . 2 . Inability provide inform consent complete study procedure within 10 hour and/or correctly , determine Principal Investigator Coinvestigators . 3 . Any physical visual impairment would prevent completion cognitive task . 4 . Participation ( within last 6 month ) study center involve similar cognitive testing procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>positron emission tomography</keyword>
	<keyword>nicotine receptor</keyword>
</DOC>